Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology

被引:23
作者
Dror, Y
Grunebaum, E
Hitzler, J
Narendran, A
Ye, C
Tellier, R
Edwards, V
Freedman, MH
Roifman, CM
机构
[1] Univ Toronto, Hosp Sick Children, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Hosp Sick Children, Div Hematol & Oncol, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Hosp Sick Children, Dept Pediat, Program Infect Immun Injury & Repair, Toronto, ON M5G 1X8, Canada
[4] Univ Toronto, Hosp Sick Children, Res Inst, Program Canc & Blood, Toronto, ON M5G 1X8, Canada
[5] Univ Toronto, Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada
关键词
D O I
10.1203/01.PDR.0000111286.23110.F8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purine nucleoside phosphorylase (PNP) deficiency is an autosomal recessive metabolic disorder characterized by severe combined immunodeficiency and by complex neurologic symptomatology including ataxia, developmental delay, and spasticity. Herein we report severe marrow dysplasia in a patient with PNP deficiency. Drug-related marrow dysfunction was unlikely, and marrow virological studies were negative. A preleukemic myelodysplastic syndrome was also unlikely due to normal marrow CD34+ cells, colony growth in clonogenic assay of marrow mononuclear cells, apoptosis rate, and Fas expression on marrow nucleated cells, as well as morphologic improvement of the marrow dysplasia after normal red blood cell transfusion. The patient's marrow stroma showed hypersensitivity to irradiation and undetectable PNP enzyme activity similar to peripheral lymphocytes. This is the first report of PNP deficiency associated with increased lymphocyte and marrow stromal sensitivity to irradiation. We conclude that marrows from patients with PNP deficiency might have hypersensitivity to irradiation and can develop dysplastic morphology, caused either directly or indirectly by the inherited enzymatic defect.
引用
收藏
页码:472 / 477
页数:6
相关论文
共 37 条
  • [1] ANDREWS LG, 1992, J BIOL CHEM, V267, P7834
  • [2] Arpaia E, 2000, ADV EXP MED BIOL, V486, P41
  • [3] AUST MR, 1992, AM J HUM GENET, V51, P763
  • [4] Carpenter PA, 1996, BONE MARROW TRANSPL, V17, P121
  • [5] CASTRO M, 1991, J RHEUMATOL, V18, P721
  • [6] DEOXYGUANOSINE TRIPHOSPHATE AS A POSSIBLE TOXIC METABOLITE IN IMMUNODEFICIENCY ASSOCIATED WITH PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY
    COHEN, A
    GUDAS, LJ
    AMMANN, AJ
    STAAL, GEJ
    MARTIN, DW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (05) : 1405 - 1409
  • [7] Immunodeficiency caused by purine nucleoside phosphorylase deficiency
    Cohen, A
    Grunebaum, E
    Arpaia, E
    Roifman, CM
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2000, 20 (01) : 143 - +
  • [8] Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient
    Dalal, I
    Grunebaum, E
    Cohen, A
    Roifman, CM
    [J]. CLINICAL GENETICS, 2001, 59 (06) : 430 - 437
  • [9] Della Rossa A, 1998, CLIN RHEUMATOL, V17, P515
  • [10] Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment
    Dror, Y
    Freedman, MH
    [J]. BLOOD, 1999, 94 (09) : 3048 - 3054